The Plasma Proteome in Community-acquired Pneumonia: Pathophysiology, Outcome and 10-Year Risk

  • 0Amsterdam UMC Locatie AMC, Amsterdam, Netherlands; e.h.michels@amsterdamumc.nl.

Summary

This summary is machine-generated.

This study mapped the plasma proteome in community-acquired pneumonia (CAP) patients, identifying proteins linked to disease severity and patient outcomes. These findings offer insights into CAP pathophysiology and potential personalized treatment strategies.

Area Of Science

  • Biochemistry
  • Immunology
  • Genomics

Background

  • Community-acquired pneumonia (CAP) poses a significant global health challenge.
  • Understanding the molecular underpinnings of CAP is crucial for improving patient care.

Purpose Of The Study

  • To comprehensively map the plasma proteome in patients with CAP.
  • To correlate protein abundance with CAP pathophysiology, tissue of origin, and clinical outcomes.
  • To identify potential biomarkers for disease severity and prognosis.

Main Methods

  • Plasma proteomic profiling of CAP patients using Olink technology across derivation and validation cohorts.
  • Inclusion of patients from general wards, intensive care units (ICUs), and SARS-CoV-2 pneumonia cases.
  • Analysis of protein abundance in relation to clinical outcomes like time to clinical stability (TCS) and survival.

Main Results

  • Analysis of 2676 proteins revealed significant differential abundance in CAP patients compared to controls.
  • Elevated protein levels were associated with innate immune responses and mitosis pathways, originating from lung and cardiac tissues.
  • 131 proteins were linked to TCS, with 124 correlating with prolonged recovery; these proteins were also differentially abundant in non-survivors.
  • Longitudinal analysis in the UK Biobank showed associations between specific proteins and future pneumonia risk.

Conclusions

  • The study presents a comprehensive, publicly available plasma proteome map for CAP.
  • Findings elucidate pathophysiological mechanisms and tissue involvement in CAP.
  • The identified proteins may serve as targets for developing personalized therapies and improving diagnostic strategies.

Related Concept Videos

Pneumonia II: Pathophysiology 01:29

603

The pathophysiology of pneumonia involves the following steps:

• Inhalation of Infectious Agents: Pneumonia typically begins when pathogenic organisms (bacteria, viruses, fungi) are inhaled or aspirated into the lower respiratory tract.


• Overcoming Lung Defenses: Ideally, the respiratory tract has defense mechanisms like mucociliary clearance and cough reflex to prevent the establishment of pathogenic organisms. If these defenses are compromised, or the pathogen is highly...

Pneumonia I: Introduction 01:30

345

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia III: Complications and Assessment 01:30

453

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

• Pleurisy: indicates the inflammation of the pleura, which causes chest pain and discomfort.
• Pleural Effusion: indicates fluid buildup in the pleural space.
• Atelectasis: Partial collapse of a lung lobe due to mucus blockage or external compression.
• Bacteremia: Bacterial infection entering the bloodstream, commonly seen with...

Pneumonia V: Nursing management and Prevention 01:30

2.5K

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumonia IV: Management 01:28

456

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

• For...

COPD: Pathogenesis and Clinical Features 01:20

535

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...